Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,283
  • Shares Outstanding, K 8,292
  • Annual Sales, $ 32,200 K
  • Annual Income, $ -140,780 K
  • 60-Month Beta 1.50
  • Price/Sales 0.32
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade XXII with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -34.88
  • Most Recent Earnings $-12.48 on 11/06/23
  • Next Earnings Date 05/28/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2111 Cigarettes

    Tobacco

    Bottom 100 Stocks

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 60.91%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,002.64% on 01/19/24
  • IV Low 0.00% on 05/24/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 18,401
  • Open Int (30-Day) 18,448

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2300 +0.81%
on 05/24/24
1.9700 -37.06%
on 04/26/24
-0.6000 (-32.61%)
since 04/24/24
3-Month
1.2300 +0.81%
on 05/24/24
4.3100 -71.23%
on 04/05/24
-0.9840 (-44.24%)
since 02/23/24
52-Week
1.2300 +0.81%
on 05/24/24
164.4000 -99.25%
on 05/25/23
-160.7600 (-99.23%)
since 05/24/23

Most Recent Stories

More News
22nd Century Group Reports First Quarter 2024 Financial Results

New Contracts to Boost Second Quarter RevenueReduced Operating Costs, Improved Cash Position Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024Mocksville, North Carolina--(Newsfile...

XXII : 1.2400 (-0.80%)
22nd Century Eliminates an Additional $2.3 Million of Debt

Continues to Improve Balance Sheet and Move Toward Cash Positive OperationsMocksville, North Carolina--(Newsfile Corp. - May 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company...

XXII : 1.2400 (-0.80%)
22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024

Mocksville, North Carolina--(Newsfile Corp. - May 8, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present...

XXII : 1.2400 (-0.80%)
22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024

Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live...

XXII : 1.2400 (-0.80%)
22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction

Improves Balance Sheet, Eliminates Future Omnia Interest Expense and Increases Shareholder EquityMocksville, North Carolina--(Newsfile Corp. - April 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII),...

XXII : 1.2400 (-0.80%)
22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors

Intends to Reduce Board to Four Seats in Upcoming ProxyMocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine...

XXII : 1.2400 (-0.80%)
22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule

Continues Focus on Growing Sales with New Contracts, Progress Toward Cash Positive OperationsMocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco...

XXII : 1.2400 (-0.80%)
22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024

Mocksville, North Carolina--(Newsfile Corp. - April 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present...

XXII : 1.2400 (-0.80%)
22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products

Pinnacle Branded Products Growing At Over 10% at Top-5 U.S. C-Store ChainMocksville, North Carolina--(Newsfile Corp. - April 11, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company...

XXII : 1.2400 (-0.80%)
22nd Century Announces Plan to Eliminate Its Senior Secured Debt

Company Bolsters Balance Sheet with $4.2 Million Capital InfusionNew Senior Leadership Team Announced to Further Drive Shareholder ValueMocksville, North Carolina--(Newsfile Corp. - April 8, 2024) - 22nd...

XXII : 1.2400 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

3rd Resistance Point 1.3532
2nd Resistance Point 1.3265
1st Resistance Point 1.2833
Last Price 1.2400
1st Support Level 1.2134
2nd Support Level 1.1867
3rd Support Level 1.1435

See More

52-Week High 164.4000
Fibonacci 61.8% 102.0691
Fibonacci 50% 82.8150
Fibonacci 38.2% 63.5609
Last Price 1.2400
52-Week Low 1.2300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar